Your browser doesn't support javascript.
loading
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology.
Naidoo, Jarushka; Murphy, Catherine; Atkins, Michael B; Brahmer, Julie R; Champiat, Stephane; Feltquate, David; Krug, Lee M; Moslehi, Javid; Pietanza, M Catherine; Riemer, Joanne; Robert, Caroline; Sharon, Elad; Suarez-Almazor, Maria E; Suresh, Karthik; Turner, Michelle; Weber, Jeffrey; Cappelli, Laura C.
Afiliação
  • Naidoo J; Oncology, Beaumont RCSI Cancer Centre, Dublin, Ireland jnaidoo1@jhmi.edu.
  • Murphy C; RCSI university of Health Sciences, Beaumont RSCI Cancer Centre, Dublin, Ireland.
  • Atkins MB; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
  • Brahmer JR; Department of Oncology, St Vincents University Hospital, Dublin, Ireland.
  • Champiat S; Department of Oncology, Beaumont Hospital, Beaumont RCSI Cancer Centre, Dublin, Ireland.
  • Feltquate D; Oncology, Georgetown University, Washington, District of Columbia, USA.
  • Krug LM; Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Moslehi J; Institut Gustave-Roussy, Villejuif, France.
  • Pietanza MC; Palleon Pharmaceuticals, Waltham, Massachusetts, USA.
  • Riemer J; AstraZeneca, New York, New York, USA.
  • Robert C; UCSF, San Francisco, California, USA.
  • Sharon E; Merck, Kenilworth, New Jersey, USA.
  • Suarez-Almazor ME; Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Suresh K; Institut Gustave-Roussy, Villejuif, France.
  • Turner M; Paris-Saclay University, Gif-sur-Yvette, France.
  • Weber J; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Cappelli LC; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Immunother Cancer ; 11(3)2023 03.
Article em En | MEDLINE | ID: mdl-37001909

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article